Trademark Search in Canada

REGENXBIO & DESIGN

View On IC.GC.CA

REGISTERED

on 2 Aug 2018

Last Applicant/ Owned by

REGENXBIO INC.

9804 Medical Center DriveRockville, Maryland 20850

Serial Number

1719710 filed on 17^th Mar 2015

Registration Number

TMA1002089 registered on 2^th Aug 2018

Registration expiry Date

2^th Aug 2033

Correspondent Address

OYEN WIGGS GREEN & MUTALA LLP

480-THE STATION, 601 WEST CORDOVA STREETVANCOUVER

BRITISH COLUMBIA

V6B1G1

REGENXBIO & DESIGN

Trademark usage description

custom development of biochemical reagents, namely, synthesis for others of clinical medical reagents for use in gene therapy, development of pharmace Read More

Vienna Information

25 . 7 . 1

Surfaces or backgrounds covered with repeated geometrical figures or designsSurfaces ou fonds couverts de figures ou de motifs géométriques répétés

25 . 7 . 6

Surfaces or backgrounds covered with circles or ellipsesSurfaces ou fonds couverts de cercles ou d'ellipses

25 . 7 . 7

Surfaces or backgrounds covered with dotsSurfaces ou fonds couverts de points

1 . 13 . 1

Armillary spheres, planetaria, astronomic orbits, atomic models, molecular modelsSphères armillaires, planétariums, orbites astronomiques, schémas d'atomes, schémas de molécules

1 . 13 . 15

Atomic models, molecular models, representations of human, animal or vegetal cellsSchémas atomiques, schémas de molécules, représentations de cellules humaines, animales ou végétales

26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

26 . 1 . 10

Circles or ellipses containing one or more triangles or lines forming an angleCercles ou ellipses contenant un ou plusieurs triangles ou des lignes formant un angle

Classification Information

Class [042]
Custom development of biochemical reagents, namely, synthesis for others of clinical medical reagents for use in gene therapy, development of pharmaceutical preparations for use in gene therapy, and therapeutic compositions that include recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy, RNA interference (RNAi); scientific research and development in the field of gene therapeutics, medical research services, genetic engineering services, biotechnology services, namely, research and development of new products in the field of gene therapeutics and research tools, including those based on recombinant adeno-associated viral vectors.

Classification kind code

Mark Details

Serial Number

1719710

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 26 on 12^th Oct 2017	Approved
Submitted for opposition 27 on 23^rd Aug 2017	Approval Notice Sent
Submitted for opposition 15 on 19^th Dec 2016	Correspondence Created
Submitted for opposition 15 on 8^th Jun 2016	Correspondence Created
Submitted for opposition 22 on 26^th Nov 2015	Search Recorded
Submitted for opposition 20 on 26^th Nov 2015	Examiner's First Report
Submitted for opposition 135 on 7^th May 2015	Amendment to Application
Submitted for opposition 31 on 19^th Mar 2015	Formalized
Submitted for opposition 1 on 18^th Mar 2015	Created
Submitted for opposition 30 on 17^th Mar 2015	Filed